S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents

Acta Biomaterialia

Volumn 12, Issue 1, 2015, Pages 62-69

  Lu, Yuan ^a   Shah, Anand ^a   Hunter, Rebecca A ^a   Soto, Robert J ^a   Schoenfisch, Mark H ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Ascorbic acid; Chitosan; Nitric oxide; S Nitrosothiol; Synergy

Indexed keywords

BACTERIA; CELL CULTURE; CHITOSAN; NITRIC OXIDE; OLIGOSACCHARIDES; REDUCTION;

2-IMINOTHIOLANE; ACETAMIDO; CHITOSAN OLIGOSACCHARIDE; LOG REDUCTIONS; MODIFIED CHITOSAN; NITRIC OXIDE RELEASE; NITROSATION; S-NITROSOTHIOL; SYNERGY; SYNTHESISED;

ASCORBIC ACID;

2 IMINOTHIOLANE; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; ASCORBIC ACID; CHITOSAN; NITRIC OXIDE; OLIGOSACCHARIDE; S NITROSOTHIOL;

ANIMAL CELL; ARTICLE; BACTERIAL VIABILITY; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; FIBROBLAST; MOUSE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; ANIMAL; CHEMISTRY; DRUG EFFECTS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; CHITOSAN; FIBROBLASTS; MICE; NITRIC OXIDE; OLIGOSACCHARIDES; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PSEUDOMONAS AERUGINOSA; S-NITROSOTHIOLS;

EID: 84923328080     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.10.028     Document Type: Article

References (52)

1. Robson MC. Wound infection - a failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997;77:637-50.
2. Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 2007;5:175-86.
3. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004;10:S122-9.
4. Marletta MA, Tayeh MA, Hevel JM. Unraveling the biological significance of nitric oxide. BioFactors 1990;2:219-25.
5. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
6. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-25.
7. Carpenter AW, Schoenfisch MH. Nitric oxide release: part II. Therapeutic applications. Chem Soc Rev 2012;41:3742-52.
8. Coneski PN, Schoenfisch MH. Nitric oxide release: part III. Measurement and reporting. Chem Soc Rev 2012;41:3753-8.
9. Lu Y, Slomberg DL, Shah A, Schoenfisch MH. Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents. Biomacromolecules 2013;14:3589-98.
10. Lu Y, Slomberg DL, Sun B, Schoenfisch MH. Shape- and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods. Small 2013;9:2189-98.
11. Lu Y, Sun B, Li C, Schoenfisch MH. Structurally diverse nitric oxide-releasing poly(propylene imine) dendrimers. Chem Mater 2011;23:4227-33.
12. Nichols SP, Storm WL, Koh A, Schoenfisch MH. Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues. Adv Drug Delivery Rev 2012;64:1177-88.
13. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009;30:2782-9.
14. Riccio DA, Schoenfisch MH. Nitric oxide release: part I. Macromolecular scaffolds. Chem Soc Rev 2012;41:3731-41.
15. Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces 2013;5:9322-9.
16. Sun B, Slomberg DL, Chudasama SL, Lu Y, Schoenfisch MH. Nitric oxidereleasing dendrimers as antibacterial agents. Biomacromolecules 2012;13:3343-54.
17. Koh A, Lu Y, Schoenfisch MH. Fabrication of nitric oxide-releasing porous polyurethane membranes-coated needle-type implantable glucose biosensors. Anal Chem 2013;85:10488-94.
18. Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS Nano 2011;5:7235-44.
19. Tan LJ, Wan AJ, Li HL. Conjugating S-nitrosothiols with glutathiose stabilized silver sulfide quantum dots for controlled nitric oxide release and nearinfrared fluorescence imaging. ACS Appl Mater Interfaces 2013;5:11163-71.
20. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan - a versatile semisynthetic polymer in biomedical applications. Prog Polym Sci 2011;36:981-1014.
21. Jayakumar R, Prabaharan M, Nair SV, Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotech Adv 2010;28:142-50.
22. Valmikinathan CM, Mukhatyar VJ, Jain A, Karumbaiah L, Dasari M, Bellamkonda RV. Photocrosslinkable chitosan based hydrogels for neural tissue engineering. Soft Matter 2012;8:1964-76.
23. Zhang JL, Xia WS, Liu P, Cheng QY, Tahirou T, Gu WX, et al. Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 2010;8:1962-87.
24. Tan LJ, Wan A, Li HL. Ag2S quantum dots conjugated chitosan nanospheres toward light-triggered nitric oxide release and near-infrared fluorescence imaging. Langmuir 2013;29:15032-42.
25. Wan A, Gao Q, Li HL. Effects of molecular weight and degree of acetylation on the release of nitric oxide from chitosan-nitric oxide adducts. J Appl Polym Sci 2010;117:2183-8.
26. Stasko NA, Schoenfisch MH. Dendrimers as a scaffold for nitric oxide release. J Am Chem Soc 2006;128:8265-71.
27. Wan A, Sun Y, Li HL. Characterization of folate-graft-chitosan as a scaffold for nitric oxide release. Int J Biol Macromol 2008;43:415-21.
28. Lu Y, Slomberg DL, Schoenfisch MH. Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. Biomaterials 2014;35:1716-24.
29. Williams DLH. The chemistry of S-nitrosothiols. Acc Chem Res 1999;32:869-76.
30. Wang PG, Xian M, Tang XP, Wu XJ, Wen Z, Cai TW, et al. Nitric oxide donors: chemical activities and biological applications. Chem Rev 2002;102:1091-134.
31. Cursino L, Chartone-Souza E, Nascimento AMA. Synergic interaction between ascorbic acid and antibiotics against Pseudomonas aeruginosa. Braz Arch Biol Technol 2005;48:379-84.
32. Holmes AJ, Williams DLH. Reaction of ascorbic acid with S-nitrosothiols: clear evidence for two distinct reaction pathways. J Chem Soc, Perkin Trans 2000;2:1639-44.
33. Chang KLB, Tai MC, Cheng FH. Kinetics and products of the degradation of chitosan by hydrogen peroxide. J Agric Food Chem 2001;49:4845-51.
34. Maghami GG, Roberts GAF. Evaluation of the viscometric constants for chitosan. Makromol Chem 1988;189:195-200.
35. Bernkop-Schnurch A, Hornof M, Zoidl T. Thiolated polymers - thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 2003;260:229-37.
36. Moynihan HA, Roberts SM. Preparation of some novel S-nitroso compounds as potential slow-release agents of nitric oxide in vivo. J Chem Soc, Perkin Trans 1994;1:797-805.
37. Tokura S, Ueno K, Miyazaki S, Nishi N. Molecular weight dependent antimicrobial activity by chitosan. Macromol Symp 1997;120:1-9.
38. Hetrick EM, Schoenfisch MH. Analytical chemistry of nitric oxide. Annu Rev Anal Chem (Palo Alto Calif) 2009;2:409-33.
39. Bernkop-Schnurch A, Zarti H, Walker GF. Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N. J Pharm Sci 2001;90:1907-14.
40. Clausen AE, Bernkop-Schnurch A. In vitro evaluation of the permeationenhancing effect of thiolated polycarbophil. J Pharm Sci 2000;89:1253-61.
41. Clausen AE, Kast CE, Bernkop-Schnurch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 2002;19:602-8.
42. Riccio DA, Coneski PN, Nichols SP, Broadnax AD, Schoenfisch MH. Photoinitiated nitric oxide-releasing tertiary S-nitrosothiol-modified xerogels. ACS Appl Mater Interfaces 2012;4:796-804.
43. Bartberger MD, Houk KN, Powell SC, Mannion JD, Lo KY, Stamler JS, et al. Theory, spectroscopy, and crystallographic analysis of S-nitrosothiols: conformational distribution dictates spectroscopic behavior. J Am Chem Soc 2000;122:5889-90.
44. Stasko NA, Fischer TH, Schoenfisch MH. S-Nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules 2008;9:834-41.
45. Price AR, Limberis MP, Wilson JM, Diamond SL. Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration. Gene Ther 2007;14:1594-604.
46. Singh RJ, Hogg N, Joseph J, Kalyanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem 1996;271:18596-603.
47. Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, et al. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2008;2:235-46.
48. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15:194-222.
49. Pruitt BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998;22:135-45.
50. Rawal BD. Bactericidal action of ascorbic acid on Pseudomonas aeruginosa - alteration of cell surface as a possible mechanism. Chemotherapy 1978;24:166-71.
51. Dawis MA, Isenberg HD, France KA, Jenkins SG. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J Antimicrob Chemother 2003;51:1203-11.
52. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-6.